XML 39 R29.htm IDEA: XBRL DOCUMENT v3.21.1
Stock Options (Tables)
9 Months Ended
Mar. 31, 2021
Fair Value Measurement Inputs and Valuation Techniques

    

2021

 

Risk-free interest rates

 

0.62

%

Expected lives

 

10

Expected volatility

 

45

%

Expected dividend yields

 

0

%

2012 Employee Plan  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

    

2020

 

Risk-free interest rates

1.30% - 2.10

%

Expected lives

10 years

Expected volatility

44-46

%

Expected dividend yields

0

%

Schedule of Share-based Compensation, Stock Options, Activity

2021

2020

Weighted average

Weighted average

    

Options

    

exercise price

    

Options

    

exercise price

Outstanding, beginning of year

117,840

$

18.84

72,500

$

11.01

Granted

41,000

27.76

Exercised

(1,800)

 

11.39

 

(14,100)

 

7.57

Forfeited

(4,000)

8.15

Outstanding, end of period

112,040

$

19.34

 

99,400

$

18.41

Exercisable, end of period

44,600

$

15.84

 

36,900

$

13.27

Weighted average fair value at grant date of options granted

n/a

 

$

15.28

 

Total intrinsic value of options exercised

$

42,000

255,000

 

Total intrinsic value of options outstanding

$

1,735,000

$

241,000

 

Total intrinsic value of options exercisable

$

847,000

$

172,000

 

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range

Options outstanding

Options exercisable

    

    

Weighted average

    

    

    

Number

remaining

Weighted average

Number

Weighted average

Range of exercise prices

outstanding

contractual life

exercise price

exercisable

exercise price

$4.37‑$33.59

112,040

7.7

$

19.34

44,600

$

15.84

2012 Non-Employee Plan  
Schedule of Share-based Compensation, Stock Options, Activity

2021

2020

    

    

Weighted average

    

    

Weighted average

Options

exercise price

Options

exercise price

Outstanding, beginning of year

12,000

$

10.29

10,200

$

7.99

Granted

1,800

23.35

Exercised

(1,200)

 

8.70

 

 

Outstanding, end of period

10,800

$

10.47

 

12,000

$

10.29

Exercisable, end of period

7,320

$

9.15

 

5,760

$

8.35

Weighted average fair value at grant date of options granted

n/a

12.94

 

  

Total intrinsic value of options exercised

$

31,000

n/a

 

  

Total intrinsic value of options outstanding

$

263,000

$

73,000

 

  

Total intrinsic value of options exercisable

$

188,000

$

42,000

 

  

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range

Options outstanding

Options exercisable

Weighted average

Weighted

Weighted

Number

remaining

average exercise

Number

average exercise

Range of exercise prices

outstanding

    

contractual life

price

    

exercisable

price

$4.37 - $23.35

10,800

6.4

$

10.47

7,320

$

9.15

2018 Non-Employee Plan  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

2020

 

Risk-free interest rates

1.60 - 1.80

%

Expected lives

10 years

Expected volatility

44 - 45

%

Expected dividend yields

%

Schedule of Share-based Compensation, Stock Options, Activity

2021

2020

    

    

Weighted average

    

    

Weighted average

Options

 

exercise price

Options

 

exercise price

Outstanding, beginning of year

48,400

$

23.48

15,200

$

16.20

Granted

 

 

33,200

 

26.82

Exercised

(1,600)

 

16.20

 

 

Outstanding, end of period

46,800

$

23.73

 

48,400

$

23.48

Exercisable, end of period

20,480

$

23.08

 

12,240

$

21.96

Weighted average fair value at grant date of options granted

n/a

$

15.09

Total intrinsic value of options exercised

$

30,000

n/a

Total intrinsic value of options outstanding

$

519,000

$

Total intrinsic value of options exercisable

$

241,000

$

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range

Options outstanding

Options exercisable

    

    

Weighted average

    

Weighted

    

    

Weighted

Number

remaining

average exercise

Number

average exercise

Range of exercise prices

outstanding

contractual life

price

exercisable

price

$16.20-$30.54

46,800

 

8.4

$

23.73

 

20,480

$

23.08

2020 Non-Employee Plan  
Schedule of Share-based Compensation, Stock Options, Activity

2021

Weighted average

    

Options

    

exercise price

Outstanding, beginning of year

 

 

Granted

 

5,000

$

22.80

Exercised

 

 

Outstanding, end of period

 

5,000

$

22.80

Exercisable, end of period

 

1,000

$

22.80

Weighted average fair value at grant date of options granted

$

12.20

 

  

Total intrinsic value of options exercised

 

n/a

 

  

Total intrinsic value of options outstanding

$

60,000

 

  

Total intrinsic value of options exercisable

$

12,000

 

  

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range

Options outstanding

Options exercisable

Weighted average

Number

remaining

Weighted average

Number

Weighted average

Range of exercise prices

    

outstanding

    

contractual life

    

exercise price

    

exercisable

    

exercise price

$22.80

 

5,000

 

9.4

$

22.80

 

1,000

$

22.80